MPLX LP (MPLX): what the price assumes

boothcheck covers MPLX LP (MPLX) but does not put one priced-in number on it: here the defensible answer is the evidence rather than a point estimate. boothcheck publishes no house fair value, target price, or buy/sell rating. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/MPLX

Headline

FieldValue
TickerMPLX
CompanyMPLX LP
Current price$59.25/sh
CompositionCrude Oil and Products Logistics 75% / Natural Gas and NGL Services 25%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)12.0%
Operating margin today44.8%
Margin compression (value-band)-32.8pp
Multiple paid14x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.

Solve inputs: computed at a 7% cost of capital with 4% terminal growth over a 5-year stage (computed at the 7% minimum rate; the CAPM rate 7% sits below it).

Reconcile: at the x-ray's 9.3% required return this reads ~6.4%/yr; the models below use their own rates.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.54σ
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset—0—
Earnings1.33x4expensive
Relative1.24x5expensive
Growth0.88x3justifies

Families that justify the price: Relative, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.8%); the inversion above states its own rate.

Per-Model Detail (n=12)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$123.030.48xyesFCF base $4.0B, growth 6% (input: historical growth), terminal g 4.0%, WACC 6.8%, 5yr projection
DCF Exit MultipleGrowth$67.690.88xyesExit EV/EBITDA: 11.9x / 13.9x / 15.9x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelative$68.360.87xyesP/E 18x (static sector reference · 2026-04), scenarios: 15.1x / 18.0x / 20.9x (bear / base = reference held flat / bull), EV/EBITDA 12x
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset——no—
Two-Stage Excess ReturnAsset——no—
Discounted Future Market CapGrowth$46.471.28xyesRev $12.9B, growth 6% (input: historical growth; tapered), Terminal P/S: 3.9x / 4.7x / 5.4x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$56.021.06xyesEPS $4.67, growth 7% (input: historical EPS growth), PEG=1.85 (Overvalued)
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings$40.141.48xyesNormalized EBIT (5y avg op income, one-time charges added back) $4.46B × (1−0%) / WACC 6.8% → EPV (no growth)
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative$47.801.24xyesEBITDA $6.11B × sector EV/EBITDA 12.0x
FCF YieldEarnings$17.083.47xyesFCF $3894.0M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$86.790.68xyesEPS $4.67 × (8.5 + 2×6.8%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$31.811.86xyesRevenue $12.91B × sector P/S 2.5x
PEG Fair ValueRelative$47.911.24xyesEPS $4.67 × (PEG 1.5 × growth 6.8% (input: historical EPS growth)) → PE 10.3x
Earnings YieldEarnings$50.471.17xyesEPS $4.67 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net debt$26.0b
Net debt / NOPAT (after-tax)4.50x
Net debt / operating income (pre-tax)4.49x
Interest coverage5.1x
Burning cashno

Bullet Takeaways

At $56.83 most of the standard valuation methods sit above the price, not below it.

The cash return is the anchor. MPLX raised its quarterly distribution 12.5% to about $4.31 annualized, a forward yield near 7.71%, with distribution coverage of 1.3x. This is a fee-based midstream system being valued like a slow-melting bond.

The two cautions are the parent relationship and the leverage. A large share of volume runs through Marathon Petroleum, and net debt of about $26 billion sits at roughly 4.5x operating income, so the steady distribution rests on a single anchor customer and a levered balance sheet.

Bull Case

The striking thing in the numbers is how far the price sits below where the methods land. At $56.83 (June 27, 2026) the DCF Perpetual Growth model reaches $127, the EV/EBITDA-relative method $48, the DCF Exit Multiple $66, and the reverse-DCF normalized band runs from roughly $106 to $135. The price is so low relative to the cash the system produces that the inversion flags it as below the floor: it sits beneath what even a 5%-a-year decline in operating profit would justify. For a fee-based pipeline and processing business, that is the model's way of saying the market is pricing in shrinkage that the assets are not showing.

The distribution makes the cheapness tangible. MPLX raised its quarterly payout 12.5% to about $4.31 annualized, a forward yield near 7.71%, and did so with distribution coverage of 1.3x, meaning it is paying out comfortably less than it generates. The business is built on fee-based services where, as the filing describes, MPLX "takes control of the product and is the principal" in the product-sales it does conduct after services are provided (FY2025 10-K, accession 0001552000-26-000009), but the core economics are toll-like fees on volume rather than commodity price exposure. A 44.8% current operating margin underlines how profitable that toll model is.

The growth is funded and visible. MPLX is advancing a $2.4 billion organic plan focused on Permian and Marcellus infrastructure, including the Harmon Creek III gas plant, Titan sour-gas treating expansion, and pipeline and fractionation projects slated to come into service between late 2026 and 2029, with management guiding those investments to mid-teens returns. Interest coverage near 5.1x supports the build. The bull case is simple: a high-coverage 7.7% yield on a fee-based system that is also growing, trading below where nearly every valuation method says the cash stream is worth.

Bear Case

The competitive risk that matters most is structural dependence. MPLX was built around Marathon Petroleum, and its volumes, contracts, and even its marine and logistics assets trace back to that relationship, with the filing referencing agreements "by and between Marathon Petroleum Company LP" and MPLX affiliates across its asset base (FY2025 10-K, accession 0001552000-26-000009). A midstream system whose anchor customer is a single refiner inherits that refiner's throughput decisions: if Marathon reconfigures runs, idles capacity, or shifts sourcing, MPLX's fee volumes move with it regardless of how the broader energy market behaves. The steady distribution that defines the bull case is only as steady as that one relationship.

The broader competitive field is also disrupting the toll model from below. MPLX competes with the largest midstream operators, Williams, ONEOK, Kinder Morgan, Targa, Energy Transfer, and Enterprise Products, for the same Permian and Marcellus volumes, and the filing names a more insidious threat: customers building their own infrastructure "in lieu of using our services." It warns that "as a consequence of the increase in competition in the industry, as well as the volatility of natural gas prices, end-users and utilities are reluctant to en"ter long-term commitments (accession 0001552000-26-000009). When producers self-build gathering and processing, the fee base erodes at the margin even as headline volumes look healthy.

The balance sheet leaves limited room for either risk to bite. Net debt is about $26 billion against roughly $5.8 billion of trailing operating income, near 4.5x, with only $1.5 billion of liquid assets and interest coverage around 5.1x. That leverage is typical for midstream but it means the 12.5% distribution hike and the $2.4 billion growth program are being funded alongside a heavy debt load. The Q1 2026 print already showed softening, with EPS of $0.90 missing a $1.06 estimate and revenue of $3.04 billion below forecasts. The bear case is that a levered, parent-dependent toll operator facing self-build competition can hold its distribution for a long time and still see the underlying fee base quietly shrink.

Valuation

MPLX is the rare name where the price sits below most of the methods rather than above them. The growth family is well clear of the quote: DCF Perpetual Growth at $127 and DCF Exit Multiple at $66. The earnings and relative families are mixed but generally above or near the price: Earnings Power Value at $41, EV/EBITDA Relative at $48, P/Sales at $32. Against $56.83, the picture is a fee-based system whose central methods imply more value than the market is assigning, with the low-end FCF-yield method ($17) reflecting the conservative no-growth capitalization rather than the franchise.

The inversion makes the cheapness explicit and is careful about how to state it. At $56.83 the market is paying about 14x company-wide operating income, a multiple so low that the price sits below what even a 5%-a-year operating-profit decline would warrant. That is a bound, not a solved growth rate: the right reading is that the price is beneath the level a modest decline would justify, not that any particular growth number is implied. The reverse-DCF normalized band runs from roughly $106 to $135 with a base near $131, computed at a 7% cost of capital, which is why the mode reads as below-floor.

The honest caveat is that the comparison data is limited, so the within-range label should be read directionally. Midstream MLPs carry leverage and parent-concentration that the generic methods do not fully penalize, and a 7.71% distribution yield is partly compensation for exactly those risks. The valuation summary is therefore two-sided: on the cash the system produces today, the price looks low against nearly every frame, and the high-coverage distribution is real. The discount exists because the steady cash depends on one anchor customer and a levered balance sheet, and the market is pricing that dependence rather than mispricing the assets.

Catalysts

The Q1 2026 results, reported in 2026, paired a soft earnings line with a stronger cash story: adjusted EBITDA of $1.7 billion, EPS of $0.90 versus a $1.06 estimate, and revenue of $3.04 billion below forecasts, alongside a first-quarter distribution of $1.0765 per unit at 1.3x coverage (PRNewswire; StockTitan). The headline catalyst was the 12.5% distribution increase to about $4.31 annualized, lifting the forward yield to roughly 7.71% (Yahoo Finance).

The forward set is the build-out, not the single quarter. MPLX is advancing a $2.4 billion organic plan across the Permian and Marcellus, including Harmon Creek III, Titan sour-gas treating, and large pipeline and fractionation projects expected in service between late 2026 and 2029, all guided to mid-teens returns (Investing.com; Simply Wall St). The swing factors into the next prints are project execution and in-service timing, the durability of fee volumes through the Marathon Petroleum relationship, distribution coverage as the growth capital is spent, and natural-gas-price effects on producer drilling that feeds MPLX's gathering and processing systems.

Sources: MPLX Q1 2026 results (PRNewswire; MPLX 8-K, 2026); Investing.com Permian-expansion coverage; Yahoo Finance distribution-hike analysis; Simply Wall St 2026 coverage.

Peer Cohorts (Per Segment, With Filing Citations)

Crude Oil and Products Logistics (reported)

Natural Gas and NGL Services (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

View the full interactive MPLX report on boothcheck